TENAPANOR

TENAPANOR was reported 3714 times

TENAPANOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCREASED DOSE ADMINISTERED 1 0.0032
1 DIALYSIS RELATED COMPLICATION 1 0.0028
2 PERICARDITIS CONSTRICTIVE 1 0.0024
3 EMBOLIC CEREBRAL INFARCTION 1 0.0015
4 URETEROLITHIASIS 1 0.0010
5 IMMEDIATE POST-INJECTION REACTION 1 0.0009
6 CHEMICAL BURN 1 0.0009
7 RECTAL ULCER 1 0.0009
8 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
9 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
10 SHOULDER FRACTURE 1 0.0006
11 ABDOMINAL WALL HAEMATOMA 1 0.0005
12 SUDDEN HEARING LOSS 1 0.0005
13 DIVERTICULAR PERFORATION 1 0.0005
14 BLOOD PHOSPHORUS INCREASED 1 0.0004
15 PRE-EXISTING CONDITION IMPROVED 2 0.0003
16 RENAL TRANSPLANT 1 0.0003
17 LIVER TRANSPLANT 1 0.0003
18 ENTEROCOCCAL INFECTION 1 0.0002
19 HYPERVOLAEMIA 1 0.0002
20 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
21 GASTRIC ULCER HAEMORRHAGE 1 0.0002
22 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
23 BLOOD IRON DECREASED 1 0.0001
24 PRODUCT TASTE ABNORMAL 1 0.0001
25 CARDIOGENIC SHOCK 1 0.0001
26 INSURANCE ISSUE 1 0.0001
27 OSTEOMYELITIS 1 0.0001
28 POST PROCEDURAL COMPLICATION 1 0.0001
29 CHOKING 1 0.0001
30 PRESCRIBED UNDERDOSE 1 0.0001
31 FEEDING DISORDER 1 0.0000
32 RETCHING 1 0.0000
33 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
34 PRODUCT PRESCRIBING ISSUE 1 0.0000
35 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
36 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
37 PNEUMONIA ASPIRATION 1 0.0000
38 SKIN ULCER 1 0.0000
39 BLOOD BILIRUBIN INCREASED 1 0.0000
40 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
41 HYPERSOMNIA 1 0.0000
42 INTESTINAL OBSTRUCTION 1 0.0000
43 SEPTIC SHOCK 1 0.0000
44 GASTROINTESTINAL DISORDER 2 0.0000
45 THROAT IRRITATION 1 0.0000
46 NEPHROLITHIASIS 1 0.0000
47 CELLULITIS 1 0.0000
48 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
49 BLISTER 1 0.0000
50 NASAL CONGESTION 1 0.0000
51 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
52 THERAPY INTERRUPTED 1 0.0000
53 MOBILITY DECREASED 1 0.0000
54 DYSGEUSIA 1 0.0000
55 INJECTION SITE HAEMORRHAGE 1 0.0000
56 COVID-19 2 0.0000
57 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
58 SWELLING 1 0.0000
59 ANAEMIA 2 0.0000
60 CONTUSION 1 0.0000
61 HEART RATE INCREASED 1 0.0000
62 SYNCOPE 1 0.0000
63 ILLNESS 1 0.0000
64 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
65 DECREASED APPETITE 2 0.0000
66 DEHYDRATION 1 0.0000
67 COUGH 2 0.0000
68 HOSPITALISATION 1 0.0000
69 ABDOMINAL DISCOMFORT 1 0.0000
70 ASTHENIA 2 0.0000
71 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
72 HYPERTENSION 1 0.0000
73 CONSTIPATION 1 0.0000
74 WEIGHT INCREASED 1 0.0000
75 ABDOMINAL PAIN 1 0.0000
76 NAUSEA 3 0.0000
77 WEIGHT DECREASED 1 0.0000
78 DIARRHOEA 2 0.0000
79 FALL 1 0.0000
80 FATIGUE 2 0.0000
81 ARTHRALGIA 1 0.0000
82 RASH 1 0.0000
83 MALAISE 1 0.0000
84 VOMITING 1 0.0000
85 DIZZINESS 1 0.0000
86 DYSPNOEA 1 0.0000
87 PAIN 1 0.0000
88 HEADACHE 1 0.0000
89 DRUG INEFFECTIVE 2 0.0000